Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obstetrics and Gynecology Reports
Published in: Current Obstetrics and Gynecology Reports 4/2015

01-12-2015 | Gynecologic Oncology (R Salani, Section Editor)

Obesity Education Strategies for Cancer Prevention in Women’s Health

Authors: Lucy Liu, Abraham Segura, Andrea R. Hagemann

Published in: Current Obstetrics and Gynecology Reports | Issue 4/2015

Login to get access

Abstract

Obesity is the cause of up to one third of all cancers affecting women today, most notably endometrial, colon, and breast cancers. Women’s health providers are poised to advise women on obesity’s link to cancer development, but often lack resources or training to provide appropriate counseling. Here, we review obesity’s role in increasing the risk of several common reproductive system conditions faced by women, including polycystic ovarian syndrome, infertility, gynecologic surgical complications, and pregnancy complications. These events can be used as teachable moments to help frame the discussion of weight management and promote cancer prevention. We also review national guidelines and existing tangible weight-loss strategies that can be employed within the outpatient women’s health setting to help women achieve weight-loss goals and affect cancer prevention.
Literature
1.
Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89(4):1213–9.PubMedCentralCrossRefPubMed
2.
Calle EE et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.CrossRefPubMed
3.
4.•
Ligibel JA et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–74. The ASCO statement on obesity management underscores the need for oncologists to address patients’ weight and facilitate weight management.CrossRefPubMed
5.•
ACOG Committee Opinion No. 600: Ethical issues in the care of the obese woman. Obstet Gynecol. 2014;123(6):1388–93. The ACOG committee opinion underscores that despite the difficulty of caring for women with obesity, we as women’s health providers are obligated to care for them and address issues most pertinent to their overall health.
6.
U.S. Department of Health and Human Services. Three steps to initiate discussion about weight management. National Institutes of Health National Heart, Lung, and Blood Institute; 2002. NIHPub ID: 02-5211.
7.
Farquhar CM et al. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol. 1999;181(3):525–9.CrossRefPubMed
8.
9.
10.
Heller DS et al. Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding. J Reprod Med. 2011;56(3-4):110–2.PubMed
11.
Smithling KR et al. Preoperative uterine bleeding pattern and risk of endometrial ablation failure. Am J Obstet Gynecol. 2014;211(5):556 e1-6.CrossRefPubMed
12.
Pare E et al. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. 2014;124(4):763–70.CrossRefPubMed
13.
14.
15.
Bilano VL et al. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLoS One. 2014;9(3), e91198.PubMedCentralCrossRefPubMed
16.
17.
18.
Phelan S. Pregnancy: a “teachable moment” for weight control and obesity prevention. Am J Obstet Gynecol. 2010;202(2):135 e1-8.CrossRefPubMed
19.
Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.CrossRefPubMed
20.
Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014;10(10):624–36.CrossRefPubMed
21.
Herber-Gast GC et al. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause. 2013;20(9):953–9.CrossRefPubMed
22.
Whiteman MK et al. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol. 2003;101(2):264–72.CrossRefPubMed
23.
24.
25.
Giugale LE et al. Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012;127(2):326–31.CrossRefPubMed
26.
Siedhoff MT et al. Effect of extreme obesity on outcomes in laparoscopic hysterectomy. J Minim Invasive Gynecol. 2012;19(6):701–7.CrossRefPubMed
27.
Morgan-Ortiz F et al. Effect of body mass index on clinical outcomes of patients undergoing total laparoscopic hysterectomy. Int J Gynaecol Obstet. 2013;120(1):61–4.CrossRefPubMed
28.
Mikhail E et al. Association between obesity and the trends of routes of hysterectomy performed for benign indications. Obstet Gynecol. 2015;125(4):912–8.CrossRefPubMed
29.
Burgio KL et al. Urinary incontinence in the 12-month postpartum period. Obstet Gynecol. 2003;102(6):1291–8.CrossRefPubMed
30.
Brown JS et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol. 1999;94(1):66–70.CrossRefPubMed
31.
Cummings JM, Rodning CB. Urinary stress incontinence among obese women: review of pathophysiology therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(1):41–4.CrossRefPubMed
32.
Hannestad YS et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003;110(3):247–54.CrossRefPubMed
33.
Richter HE et al. Factors associated with incontinence frequency in a surgical cohort of stress incontinent women. Am J Obstet Gynecol. 2005;193(6):2088–93.CrossRefPubMed
34.
Miedel A et al. Nonobstetric risk factors for symptomatic pelvic organ prolapse. Obstet Gynecol. 2009;113(5):1089–97.CrossRefPubMed
35.
36.
Bradley CS et al. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848–54.CrossRefPubMed
37.
Bianchini F, Kaaks R, Vainio H. Weight control and physical activity in cancer prevention. Obes Rev. 2002;3(1):5–8.CrossRefPubMed
38.•
Kushi LH et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67. The ACS guidelines on nutrition and physical activity provide an excellent opportunity for discussion in an office visit. Studies have shown that even minimal support and encouragement from physcians can help to facilitate change and prompt weight loss and behavioral change.CrossRefPubMed
39.
Martin PD et al. Weight loss maintenance following a primary care intervention for low-income minority women. Obesity (Silver Spring). 2008;16(11):2462–7.CrossRef
40.
Tsai AG et al. A primary care intervention for weight loss: results of a randomized controlled pilot study. Obesity (Silver Spring). 2010;18(8):1614–8.CrossRef
41.
42.
Ockene IS et al. Effect of physician-delivered nutrition counseling training and an office-support program on saturated fat intake, weight, and serum lipid measurements in a hyperlipidemic population: Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). Arch Intern Med. 1999;159(7):725–31.CrossRefPubMed
43.
Power ML, Cogswell ME, Schulkin J. Obesity prevention and treatment practices of U.S. obstetrician-gynecologists. Obstet Gynecol. 2006;108(4):961–8.CrossRefPubMed
44.
Kuroki LM et al. Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer. Gynecol Oncol Rep. 2015;12:41–4.PubMedCentralCrossRefPubMed
45.
Neff R et al. Is bariatric surgery an option for women with gynecologic cancer? Examining weight loss counseling practices and training among gynecologic oncology providers. Gynecol Oncol. 2014;134(3):540–5.PubMedCentralCrossRefPubMed
46.
Williams LT et al. Can a relatively low-intensity intervention by health professionals prevent weight gain in mid-age women? 12-Month outcomes of the 40-Something randomised controlled trial. Nutr Diabetes. 2014;4, e116.PubMedCentralCrossRefPubMed
47.
48.
49.
Smith LP, Ng SW, Popkin BM. Trends in US home food preparation and consumption: analysis of national nutrition surveys and time use studies from 1965-1966 to 2007-2008. Nutr J. 2013;12:45.PubMedCentralCrossRefPubMed
50.
Chen L et al. Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial. Am J Clin Nutr. 2009;89(5):1299–306.PubMedCentralCrossRefPubMed
51.
McCullough ML et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1089–97.CrossRefPubMed
52.
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6 Suppl 2:51S–209.
53.
54.
55.
Patel AV et al. Leisure-time spent sitting and site-specific cancer incidence in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1350–9.CrossRefPubMed
56.
Hu FB et al. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785–91.CrossRefPubMed
57.
Thelwall S, Harrington P, Sheridan E, Lamagni T. Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England. Clin Microbiol Infect. 2015. doi:10.​1016/​j.​cmi.​2015.​07.​003.
58.
Hebert JR et al. A dietitian-delivered group nutrition program leads to reductions in dietary fat, serum cholesterol, and body weight: the Worcester Area Trial for Counseling in Hyperlipidemia (WATCH). J Am Diet Assoc. 1999;99(5):544–52.CrossRefPubMed
59.
Hutchesson MJ et al. Changes to dietary intake during a 12-week commercial web-based weight loss program: a randomized controlled trial. Eur J Clin Nutr. 2014;68(1):64–70.CrossRefPubMed
60.
Tol J et al. Dietetic treatment lowers body mass index in overweight patients: an observational study in primary health care. J Hum Nutr Diet. 2014;27(5):426–33.CrossRefPubMed
61.
Donini LM et al. Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting. Eat Weight Disord. 2014;19(2):249–60.CrossRefPubMed
62.
Funk KL et al. Associations of internet website use with weight change in a long-term weight loss maintenance program. J Med Internet Res. 2010;12(3), e29.PubMedCentralCrossRefPubMed
63.
Vojta D et al. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am J Prev Med. 2013;44(4 Suppl 4):S301–6.CrossRefPubMed
64.
Gudzune KA et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162(7):501–12.CrossRefPubMed
65.
Dansinger ML et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293(1):43–53.CrossRefPubMed
66.
Gardner CD et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297(9):969–77.CrossRefPubMed
67.
Alhassan S et al. Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study. Int J Obes (Lond). 2008;32(6):985–91.CrossRef
68.
69.
70.
Torgerson JS et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.CrossRefPubMed
71.
Smith SR et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.CrossRefPubMed
72.
Fidler MC et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.CrossRefPubMed
73.
Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nat Rev Endocrinol. 2013;9(8):467–78.CrossRefPubMed
74.
Gadde KM et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–52.CrossRefPubMed
75.
Garvey WT et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297–308.PubMedCentralCrossRefPubMed
76.
Allison DB et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330–42.CrossRef
77.
Astrup A et al. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond). 2012;36(6):843–54.CrossRef
78.
Astrup A et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009;374(9701):1606–16.CrossRefPubMed
79.
Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.CrossRefPubMed
80.
Pi-Sunyer X et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.CrossRefPubMed
81.
Berne C, Orlistat Swedish G. Type 2 diabetes study, a randomized study of orlistat in combination with a weight management programme in obese patients with type 2 diabetes treated with metformin. Diabet Med. 2005;22(5):612–8.CrossRefPubMed
82.
Jacob S et al. Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss. Diabetes Obes Metab. 2009;11(4):361–71.CrossRefPubMed
83.
O’Neil PM et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012;20(7):1426–36.CrossRef
84.
Hollander P et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.PubMedCentralCrossRefPubMed
85.
Van Gaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care. 2015;38(6):1161–72.CrossRefPubMed
86.
Sjostrom L et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10(7):653–62.CrossRefPubMed
87.
Adams TD et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61.CrossRefPubMed
88.
Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med. 2014;371(7):682.PubMed
89.
Sjostrom L et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.CrossRefPubMed
90.
Sjostrom L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMed
91.
Sjostrom L et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.CrossRefPubMed
92.
Sjostrom L et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.CrossRefPubMed
93.
Kashyap SR et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175–82.PubMedCentralCrossRefPubMed
94.
Courcoulas AP et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.PubMedCentralPubMed
95.
Lindekilde N et al. The impact of bariatric surgery on quality of life: a systematic review and meta-analysis. Obes Rev. 2015;16(8):639–51.CrossRefPubMed
96.
Mechanick JI et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21 Suppl 1:S1–27.CrossRef
97.
Nguyen NT et al. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg. 2011;213(2):261–6.CrossRefPubMed
98.
Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). 2013;37(6):889–91.CrossRef
99.
Funk LM, Jolles S, Fischer LE, Voils CI. Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery: a systematic review. JAMA Surg. 2015. doi:10.​1001/​jamasurg.​2015.​1250.
100.
101.
Atwood K, Colditz GA, Kawachi I. From public health science to prevention policy: placing science in its social and political contexts. Am J Public Health. 1997;87(10):1603–6.PubMedCentralCrossRefPubMed
Metadata
Title
Obesity Education Strategies for Cancer Prevention in Women’s Health
Authors
Lucy Liu
Abraham Segura
Andrea R. Hagemann
Publication date
01-12-2015
Publisher
Springer US
Published in
Current Obstetrics and Gynecology Reports / Issue 4/2015
Electronic ISSN: 2161-3303
DOI
https://doi.org/10.1007/s13669-015-0129-8

Other articles of this Issue 4/2015

Current Obstetrics and Gynecology Reports 4/2015 Go to the issue

Management of HPV and Associated Cervical Lesions (L Denny, Section Editor)

Epidemiology and Burden of Disease Associated with HPV Infection

Management of HPV and Associated Cervical Lesions (L Denny, Section Editor)

Immunology of HPV Infection

Gynecologic Oncology (R Salani, Section Editor)

The Impact of Diabetes on Gynecologic Cancer: Current Status and Future Directions

Management of HPV and Associated Cervical Lesions (L Denny, Section Editor)

Natural History of Human Papilloma Virus Infection of the Cervix

Management of HPV and Associated Cervical Lesions (L Denny, Section Editor)

HPV Vaccination: Current Global Status

Management of HPV and Associated Cervical Lesions (L Denny, Section Editor)

Human Papillomavirus (HPV) Testing for Secondary Prevention of Cervical Cancer